These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 4729646

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).
    Hill GJ, Ruess R, Berris R, Philpott GW, Parkin P.
    Ann Surg; 1974 Aug; 180(2):167-74. PubMed ID: 4601984
    [Abstract] [Full Text] [Related]

  • 23. Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma.
    McKelvey EM, Luce JK, Talley RW, Hersh EM, Hewlett JS, Moon TE.
    Cancer; 1977 Jan; 39(1):1-4. PubMed ID: 832224
    [Abstract] [Full Text] [Related]

  • 24. [Chemotherapy of malignant melanoma].
    Wagenknecht L.
    Schweiz Med Wochenschr; 1973 Oct 13; 103(41):1426-8. PubMed ID: 4127413
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine.
    Carmo-Pereira J, Oliveira Costa F, Pimentel P.
    Cancer Treat Rep; 1976 Sep 13; 60(9):1381-3. PubMed ID: 1016972
    [No Abstract] [Full Text] [Related]

  • 27. Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.
    Johnson RO, Metter G, Wilson W, Hill G, Krementz E.
    Cancer Treat Rep; 1976 Feb 13; 60(2):183-7. PubMed ID: 769971
    [Abstract] [Full Text] [Related]

  • 28. Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin.
    Gerner RE, Moore GE, Didolkar MS.
    Cancer; 1973 Oct 13; 32(4):756-60. PubMed ID: 4751912
    [No Abstract] [Full Text] [Related]

  • 29. Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
    Gams RA, Carpenter JT.
    Cancer Chemother Rep; 1974 Oct 13; 58(5 Pt 1):753-4. PubMed ID: 4214608
    [No Abstract] [Full Text] [Related]

  • 30. Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Kline I, Woodman RJ, Gang M, Cysyk RL, Venditti JM.
    Cancer Chemother Rep; 1973 Oct 13; 57(3):291-8. PubMed ID: 4751255
    [No Abstract] [Full Text] [Related]

  • 31. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
    Carter RD, Krementz ET, Hill GJ, Metter GE, Fletcher WS, Golomb FM, Grage TB, Minton JP, Sparks FC.
    Cancer Treat Rep; 1976 May 13; 60(5):601-9. PubMed ID: 991149
    [Abstract] [Full Text] [Related]

  • 32. Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma.
    McKelvey EM, Luce JK, Vaitkevicius VK, Talley RW, Bodey GP, Lane M, Moon TE.
    Cancer; 1977 Jan 13; 39(1):5-10. PubMed ID: 832251
    [Abstract] [Full Text] [Related]

  • 33. Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma.
    Bellett RE, Mastrangelo MJ, Laucius JF, Bodurtha AJ.
    Cancer Treat Rep; 1976 May 13; 60(5):595-600. PubMed ID: 791478
    [Abstract] [Full Text] [Related]

  • 34. 5-[3,3-Bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in the treatment of childhood malignancy.
    Komp DM, Land VJ, Nitschke R, Cangir A, Dyment P.
    Cancer Chemother Rep; 1975 May 13; 59(2 Pt 1):371-6. PubMed ID: 1097094
    [No Abstract] [Full Text] [Related]

  • 35. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.
    Frei E, Luce JK, Talley RW, Vaitkevicius VK, Wilson HE.
    Cancer Chemother Rep; 1972 Oct 13; 56(5):667-70. PubMed ID: 4569060
    [No Abstract] [Full Text] [Related]

  • 36. Chemotherapy of malignant melanoma.
    Luce JK.
    Cancer; 1972 Dec 13; 30(6):1604-15. PubMed ID: 4565819
    [No Abstract] [Full Text] [Related]

  • 37. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.
    Ahmann DL, Hahn RG, Bisel HF, Eagan RT, Edmonson JH.
    Cancer Chemother Rep; 1975 Dec 13; 59(2 Pt 1):451-3. PubMed ID: 1097102
    [No Abstract] [Full Text] [Related]

  • 38. Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma.
    Nathanson L, Wolter J, Horton J, Colsky J, Shnider BI, Schilling A.
    Clin Pharmacol Ther; 1971 Dec 13; 12(6):955-62. PubMed ID: 5134998
    [No Abstract] [Full Text] [Related]

  • 39. Phase II study of 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in advanced gastrointestinal cancer.
    Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.
    Cancer Chemother Rep; 1972 Apr 13; 56(2):267-9. PubMed ID: 5043230
    [No Abstract] [Full Text] [Related]

  • 40. DTIC (NSC-45388) in malignant melanoma: a perspective.
    Comis RL.
    Cancer Treat Rep; 1976 Feb 13; 60(2):165-76. PubMed ID: 769969
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.